22157.jpg
Global Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters Devices Pipeline Report 2021: Product Description, Licensing and Collaboration Details, Developmental Activities
05 nov. 2021 10h33 HE | Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" report has...
22157.jpg
The Worldwide Balloon Catheters Industry is Expected to Reach $5.1+ Billion by 2026
07 sept. 2021 05h18 HE | Research and Markets
Dublin, Sept. 07, 2021 (GLOBE NEWSWIRE) -- The "Balloon Catheters Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global balloon catheters...
22157.jpg
Global and China PTA Balloon Catheter Markets Report 2021: Analysis & Forecasts, 2016-2020 & 2021-2026
19 mai 2021 07h28 HE | Research and Markets
Dublin, May 19, 2021 (GLOBE NEWSWIRE) -- The "Global and Chinese Pta Balloon Catheter Industry, 2021 Market Research Report" report has been added to ResearchAndMarkets.com's offering. 'Global and...
22157.jpg
Global PTA Balloon Catheters Device Pipeline Assessment 2020: Stage of Development / Segment / Territory / Regulatory Path / Estimated Approval Date / Ongoing Clinical Trials
23 déc. 2020 03h58 HE | Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "PTA Balloon Catheters - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering. "PTA Balloon...
BBRAUN SE_GREEN (1).jpg
B. Braun Interventional Systems Receives Breakthrough Device Designation Status from the FDA for SeQuent Please ReX Drug Coated PTCA Balloon Catheter
01 août 2019 09h00 HE | B. Braun Medical Inc.--US
BETHLEHEM, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- B. Braun Interventional Systems Inc. (BIS) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device...
Lubrizol expands its medical device design, development, and manufacturing capabilities with the acquisition of Bavaria Medizin Technologie GmbH.
Lubrizol übernimmt die Bavaria Medizin Technologie GmbH
15 juil. 2019 02h00 HE | Lubrizol
CLEVELAND, July 15, 2019 (GLOBE NEWSWIRE) -- Die Lubrizol Corporation gibt die Übernahme der Bavaria Medizin Technologie GmbH (BMT), eines innovativen Entwicklers und Herstellers von intravaskulären...
Lubrizol expands its medical device design, development, and manufacturing capabilities with the acquisition of Bavaria Medizin Technologie GmbH.
Lubrizol Acquires Bavaria Medizin Technologie GmbH
15 juil. 2019 02h00 HE | Lubrizol
CLEVELAND, July 15, 2019 (GLOBE NEWSWIRE) -- The Lubrizol Corporation announces the acquisition of Bavaria Medizin Technologie GmbH (BMT), an innovative designer and manufacturer of both...